Records containing: Lupus Erythematosus, Systemic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-01-13Interactive Digital Technology (Project EVO) to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2019-12-20A Randomized Controlled Trial to Investigate a Contemplation-Based Intervention and Health Outcomes in Systemic Lupus Erythematosus Patients
-
CLINICAL_TRIALS study record update · 2019-11-12A Phase I, Open-Label, Dose Escalation Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults With Active Cutaneous Lupus (ALE08)
-
CLINICAL_TRIALS study record update · 2019-10-28Repolarization Disorders and Heart Conduction Disorders in Patients With Systemic Lupus Erythematous
-
CLINICAL_TRIALS study record update · 2019-07-31A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of MEDI-546 in Adults With Systemic Lupus Erythematosus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-04-11A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2019-04-11An Open-label Study of the Safety and Tolerability of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2019-03-21A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed Protocol EMR-700461-023 (ADDRESS II)
-
CLINICAL_TRIALS study record update · 2019-03-14A Pilot Study to Investigate a Contemplation-Based Intervention and Health Outcomes in Systemic Lupus Erythematosus Patients
-
CLINICAL_TRIALS study record update · 2019-03-11Rheumatologic Biobank for Clinical and Basic Research: Isolation, Extraction and Storage of Protein, DNA and RNA Extracted From Tissues of Patients With Rheumatoid Diseases
-
CLINICAL_TRIALS study record update · 2019-02-28Synergetic B-cell Immodulation in SLE
-
CLINICAL_TRIALS study record update · 2019-02-27Prophylactic Trimethoprim-Sulfamethoxazole for the Prevention of Serious Infections in Patients With Systemic Lupus Erythematosus: a Randomized Placebo Controlled Trial
-
CLINICAL_TRIALS study record update · 2019-02-06A Phase II Multicenter, Randomized, Double-blind, Placebo Controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX-0061 Administered Subcutaneously in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2018-12-07An Ascending Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Sbi-087 Administered To Subjects With Systemic Lupus Erythematosus.
-
CLINICAL_TRIALS study record update · 2018-11-02Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)
-
CLINICAL_TRIALS study record update · 2018-08-10Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification
-
CLINICAL_TRIALS study record update · 2018-06-28Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
-
CLINICAL_TRIALS study record update · 2018-06-15Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2018-06-12A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2018-05-23Study to Assess Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of TAB08 in Patients With Systemic Lupus Erythematosus, Not Adequately Controlled With Current Concomitant Therapy
-
CLINICAL_TRIALS study record update · 2018-04-05The Heart in Systemic Lupus Erythematosus - a Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography
-
CLINICAL_TRIALS study record update · 2018-03-14A Complex Contraception Registry - UC Family Planning Collaborative Study
-
CLINICAL_TRIALS study record update · 2017-12-19A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
-
CLINICAL_TRIALS study record update · 2017-12-06Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series
-
CLINICAL_TRIALS study record update · 2017-11-27A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus